Status:
COMPLETED
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rhinitis, Allergic, Seasonal
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis t...
Detailed Description
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy and Safety of Once-Daily, Intranasal Administration of GW685698X Aqueous Nasal Spray 100mcg f...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Must be outpatients.
- Diagnosis of SAR.
- Literate in English or native language.
- Exclusion criteria:
- Have a significant concomitant medical condition.
- Use corticosteroids or other allergy medications during the study.
- Use tobacco products.
Exclusion
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
End Date :
October 1 2005
Estimated Enrollment :
288 Patients enrolled
Trial Details
Trial ID
NCT00197262
Start Date
August 1 2005
End Date
October 1 2005
Last Update
January 19 2017
Active Locations (18)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Chicago, Illinois, United States, 60637
2
GSK Investigational Site
Indianapolis, Indiana, United States, 46208
3
GSK Investigational Site
Lafayette, Indiana, United States, 47904
4
GSK Investigational Site
Louisville, Kentucky, United States, 40215